Please login to the form below

Not currently logged in
Email:
Password:

KCL appoints Luigi Martini as first chair of pharmaceutical innovation

Rainbow Medical Engineering director to lead new discoveries and inventions at King’s College London

Prof Luigi Gino Martini - King's College LondonKing's College London has appointed Rainbow Medical Engineering director Professor Luigi Martini as its first Chair of Pharmaceutical Innovation.

The newly-created position will see Martini work in the college's Institute of Pharmaceutical Science to strengthen its ability to ensure new discoveries and inventions across King's Health Partners are transferred to clinical and pharmaceutical development.

King's Health Partners is one of the UK's five academic health sciences centres, organisations that provide health care to patients and undertake health-related research. It combines the King's College London university and three NHS Foundation Trusts of Guy's and St Thomas', King's College Hospital and South London and Maudsley.

Prior to his role at Rainbow Medical, Martini was senior director of preclinical and pharmaceutical development for Emerging Markets and Asia Pacific at GlaxoSmithKline.

He is also a Fellow of the Royal Pharmaceutical Society of Great Britain, with research interests including the design of dosage form concepts for delivering personalised medicines and the development of biopharmaceuticals.

On his appointment, Martini said: “I am honoured to be joining this first-class institution, particularly in a role - the first of its kind in the UK - that demonstrates King's visionary leadership and ambition.”

6th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics